| AD | Alzheimer’s disease |
| AGEs | Advanced glycation end products |
| BDNF | Brain-derived neurotrophic factor |
| CRP | C reactive protein |
| HbA1c | Glycosylated hemoglobin |
| HOMA-IR | Insulin resistance score |
| Hp | Haptoglobin protein |
| HPA | Hypothalamic-pituitary-adrenal |
| IL-1 | Interleukin-1 |
| IL-6 | Interleukin-6 |
| MCI | Mild cognitive impairment |
| miRNA | microRNAs |
| NFTs | Neurofibrillary tangles |
| NPs | β-amyloid neurotic plaques |
| PET | Positron Emission Tomography |
| PI3K | Phosphoinositide 3-Kinase |
| RAGE | Receptor of advanced glycation end products |
| ROS | Reactive oxygen species |
| T2DM | Type 2 diabetes mellitus |
| TNF-α | Tumor necrosis factor-α |
| VD | Vascular dementia |
| WMHs | White matter hyperintensities |